CD274 and breast carcinoma: In the meta-analysis conducted by Li et al. [14], they analyzed the survival data of 7,802 patients with breast cancer, and found that PD-L1 protein expression was associated with shorter OS, shorter DFS, and shorter metastasis-free survival in these patients.